A study to establish the technical and economic feasibility of a mobile DNA and...
A study to establish the technical and economic feasibility of a mobile DNA and RNA testing tool for use in general clinics and homecare.
As DNA testing is most commonly centralised in labs, it lacks the turnaround time for time-sensitive applications, and also lacks mobility. The experience in biology required to prepare samples and carry out testing obfuscate the...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
PTQ-17-09434
INvitro DIagnostics for CAncer TEsting (INDICATE): Desarroll...
50K€
Cerrado
DI-17-09573
INvitro DIagnostics for CAncer TEsting (INDICATE): Desarroll...
43K€
Cerrado
Rapidemic
Rapidemic – A lysis buffer for a novel molecular point-of-ca...
75K€
Cerrado
SPCard
Development of a fully automated integrated solution that c...
235K€
Cerrado
DIN2021-011798
Desarrollo de un sistema Point-of-Care de diagnóstico molecu...
52K€
Cerrado
Información proyecto BiomemeDx
Duración del proyecto: 0 meses
Fecha Inicio: 2016-09-24
Fecha Fin: 2016-09-30
Líder del proyecto
GOLDSMITHS' COLLEGE
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
As DNA testing is most commonly centralised in labs, it lacks the turnaround time for time-sensitive applications, and also lacks mobility. The experience in biology required to prepare samples and carry out testing obfuscate the process and limit point-of-care applications. Biomeme seeks to break down these barriers with their versatile Dx System, a holistic solution to bring DNA testing out of the labs and into the physician’s office. Thus, Biomeme provides Molecular Diagnostics for the on-demand economy. By simplifying the process of DNA testing, without sacrificing the detail to be found in raw data, the Biomeme solution brings molecular diagnostic into point-of-care medical services, making it available for homecare and other point-of-need uses.